© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity IPOs

Top Section/Ad

Top Section/Ad

Most recent

More articles/Ad

More articles/Ad

More articles

  • Shanghai Fudan-Zhangjian Bio-Pharmaceutical Co has become the first Hong Kong-listed company to announce that it wants to float on China’s hotly-anticipated technology board.
  • China-based biotechnology firm Mabpharm is looking for the greenlight to list in Hong Kong, having filed a draft IPO prospectus with the city’s stock exchange.
  • In his latest Clawback column, Philippe Espinasse takes a look at the Hong Kong stock exchange’s new three year plan and its desire to be a global listing hub.
  • Shares in Funding Circle Holdings, the UK peer-to-peer lending platform, closed up on Thursday despite the company reporting a widening loss in 2018 because of the costs of its £440m IPO on the London Stock Exchange in September.
  • The EMEA IPO market might soon be revving back into life with several issuers hoping to price deals before Easter. Investors are watching two multi-billion deals particularly closely: the spin-off of VW’s truck division Traton and the flotation of Italian payments company Nexi.
  • Futu Holdings, the parent of Hong Kong-based Futu Securities, has pulled off the first IPO by a Chinese online brokerage. The company was on track to raise $160m on Thursday after making a late change to the deal, cutting the size of its float and adding a private placement to an international fund. Jonathan Breen reports.